e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
New treatments and old dilemmas in the clinical management of lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interest of check-up before discontinuing anti thrombotic therapy after a first episod of pulmonary embolism
E. Collinge, R. Frognier (Bouge, Belgium)
Source:
Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Session:
New treatments and old dilemmas in the clinical management of lung diseases
Session type:
Poster Discussion
Number:
3354
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Collinge, R. Frognier (Bouge, Belgium). Interest of check-up before discontinuing anti thrombotic therapy after a first episod of pulmonary embolism. Eur Respir J 2013; 42: Suppl. 57, 3354
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Hemorrhagic complications of treatment in patients with pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Evolution of pulmonary blood volume under anticoagulant therapy after a first symptomatic pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Clinical conundrums in pulmonary embolism treatment
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Home treatment of pulmonary embolism
Source: Virtual Congress 2021 – Pulmonary vascular diseases
Year: 2021
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015
Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Outpatient treatment of pulmonary embolism
Source: Breathe, 16 (3) 200069; 10.1183/20734735.0069-2020
Year: 2020
The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Thrombolytic therapy in cases with massive pulmonary thromboembolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Beyond the guidelines? Case review of thrombolysis for pulmonary embolism at a district general hospital
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Thrombolytic therapy in massive pulmonary thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 237s
Year: 2002
Bilateral chylothorax in a patient with chronic central vein thrombosis and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007
Pulmonary embolism: who should receive thrombolysis?
Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism
Year: 2014
Duration of anticoagulation after isolated pulmonary embolism
Source: Eur Respir J 2016; 47:1429-1435
Year: 2016
Global fibrinolytic profile in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept